CTOR
Citius Oncology, Inc.
1.10$
+4.0%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| – | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | 6.3% | 16.2% | 13.0% | 27.3% | |
| – | 0.7% | 0.1% | 0.0% | 3.9% | |
| – | – | – | 0.0% | 3.9% | |
| – | – | 0.0% | 9.8% | 22.1% | |
| – | 93.7% | 83.8% | 87.0% | 72.7% | |
| – | 15.0% | 46.5% | 45.3% | 55.6% | |
| – | 13.7% | 44.1% | 38.8% | 49.0% | |
| – | 0.2% | 2.7% | 4.4% | 13.1% | |
| – | – | – | 4.5% | 3.8% | |
| – | 85.0% | 53.5% | 54.7% | 44.4% | |
| – | -12.7% | -38.0% | -46.6% | -63.4% | |
| – | 211.2% | 187.5% | 84.8% | 72.6% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.